We next focused on 1p-intact neuroblastomas and studied the mutational spectrum of neuroblastoma candidate genes (particularly chromosome 1 genes CASZ1, CHD5, PTPN14, KIF1Bβ, NTRK1, and TP73), and their association with clinical prognostic variables. This evidence concerns the gene TP73 and neuroblastoma.